Report Detail
Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025
- RnM2359162 |
- 19 April, 2019 |
- Global |
- 123 Pages |
- QYResearch |
- Pharma & Healthcare
The global Nuclear Medicine/Radiopharmaceutic market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine/Radiopharmaceutic market based on company, product type, end user and key regions.
This report studies the global market size of Nuclear Medicine/Radiopharmaceutic in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine/Radiopharmaceutic in these regions.
This research report categorizes the global Nuclear Medicine/Radiopharmaceutic market by top players/brands, region, type and end user. This report also studies the global Nuclear Medicine/Radiopharmaceutic market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
China Isotope Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging
Market size by Product
Diagnostic
Therapeutic
Market size by End User
Oncology
Thyroid
Cardiology
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Nuclear Medicine/Radiopharmaceutic market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nuclear Medicine/Radiopharmaceutic market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nuclear Medicine/Radiopharmaceutic companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nuclear Medicine/Radiopharmaceutic submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine/Radiopharmaceutic market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Nuclear Medicine/Radiopharmaceutic Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Product
- 1.4.2 Diagnostic
- 1.4.3 Therapeutic
- 1.5 Market by End User
- 1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Thyroid
- 1.5.4 Cardiology
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size
- 2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2014-2025
- 2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025
- 2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions
- 2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions
- 2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
- 3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
- 3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers
- 3.1.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
- 3.2 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers
- 3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019)
- 3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019)
- 3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
- 3.4 Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
- 3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
- 3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Product
- 4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Product
- 4.3 Nuclear Medicine/Radiopharmaceutic Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Nuclear Medicine/Radiopharmaceutic Breakdown Data by End User
6 North America
- 6.1 North America Nuclear Medicine/Radiopharmaceutic by Countries
- 6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Countries
- 6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Nuclear Medicine/Radiopharmaceutic by Product
- 6.3 North America Nuclear Medicine/Radiopharmaceutic by End User
7 Europe
- 7.1 Europe Nuclear Medicine/Radiopharmaceutic by Countries
- 7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries
- 7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Nuclear Medicine/Radiopharmaceutic by Product
- 7.3 Europe Nuclear Medicine/Radiopharmaceutic by End User
8 Asia Pacific
- 8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Countries
- 8.1.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Countries
- 8.1.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic by Product
- 8.3 Asia Pacific Nuclear Medicine/Radiopharmaceutic by End User
9 Central & South America
- 9.1 Central & South America Nuclear Medicine/Radiopharmaceutic by Countries
- 9.1.1 Central & South America Nuclear Medicine/Radiopharmaceutic Sales by Countries
- 9.1.2 Central & South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Nuclear Medicine/Radiopharmaceutic by Product
- 9.3 Central & South America Nuclear Medicine/Radiopharmaceutic by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Countries
- 10.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries
- 10.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by Product
- 10.3 Middle East and Africa Nuclear Medicine/Radiopharmaceutic by End User
11 Company Profiles
- 11.1 China Isotope Radiation
- 11.1.1 China Isotope Radiation Company Details
- 11.1.2 Company Business Overview
- 11.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.1.5 China Isotope Radiation Recent Development
- 11.2 Dongcheng
- 11.2.1 Dongcheng Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Dongcheng Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.2.5 Dongcheng Recent Development
- 11.3 Jaco
- 11.3.1 Jaco Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Jaco Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.3.5 Jaco Recent Development
- 11.4 Ciaeriar
- 11.4.1 Ciaeriar Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Ciaeriar Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.4.5 Ciaeriar Recent Development
- 11.5 Advanced Molecular-imaging Solution
- 11.5.1 Advanced Molecular-imaging Solution Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.5.5 Advanced Molecular-imaging Solution Recent Development
- 11.6 Shanghai Atom Kexing
- 11.6.1 Shanghai Atom Kexing Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.6.5 Shanghai Atom Kexing Recent Development
- 11.7 Cardinal Health
- 11.7.1 Cardinal Health Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Cardinal Health Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.7.5 Cardinal Health Recent Development
- 11.8 Mallinckrodt
- 11.8.1 Mallinckrodt Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.8.5 Mallinckrodt Recent Development
- 11.9 GE Healthcare
- 11.9.1 GE Healthcare Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.9.5 GE Healthcare Recent Development
- 11.10 Lantheus Medical Imaging
- 11.10.1 Lantheus Medical Imaging Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
- 11.10.5 Lantheus Medical Imaging Recent Development
- 11.11 Bayer Healthcare
- 11.12 Bracco Imaging
- 11.13 Eczacibasi-Monrol Nuclear Products
- 11.14 Nordion
- 11.15 Advanced Accelerator Applications
- 11.16 Iba Molecular Imaging
12 Future Forecast
- 12.1 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions
- 12.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025
- 12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025
- 12.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Product
- 12.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Product 2019-2025
- 12.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Product 2019-2025
- 12.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by End User
- 12.4 North America Nuclear Medicine/Radiopharmaceutic Forecast
- 12.5 Europe Nuclear Medicine/Radiopharmaceutic Forecast
- 12.6 Asia Pacific Nuclear Medicine/Radiopharmaceutic Forecast
- 12.7 Central & South America Nuclear Medicine/Radiopharmaceutic Forecast
- 12.8 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Nuclear Medicine/Radiopharmaceutic Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Nuclear Medicine/Radiopharmaceutic . Industry analysis & Market Report on Nuclear Medicine/Radiopharmaceutic is a syndicated market report, published as Global Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Nuclear Medicine/Radiopharmaceutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
